COVID-19 vaccine: Kochi-based company gets permission for second phase of clinical trials
Thrissur: The chances of Keralites being part of efforts to tackle coronavirus has increased. Kochi headquartered PNB Vesper has been granted permission to conduct the second stage clinical trials of the vaccine.
The permission was granted after PNB-001 (GPB Baladol) performed better than Dexamethasone, which was effectively used in Britain.
The vaccine will get a production permit only if it completes three stages of testing. There had been situations where prior permission was granted based on performance in the second stage itself. The vaccine is expected to reach the market in months.
P. N. Balaram, a native of Thrissur and MD of the company, said that the testing will be concluded in two months as per the approval of the Drugs Controller General of India (DGCI).
The company is conducting research in association with organisations in USA, England, Thailand and Germany. 74 people were involved in the first phase. Studies conducted in Ahmedabad yielded excellent results.
Following this, the company sought permission to conduct the second stage of testing through Biosphere clinical Research. The tests are being conducted on 40 COVID-19 survivors at B J Government Medical College in Pune.